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ABSTRACT
Bilharzia, also known as schistosomiasis, is still affecting more than 250 million people, killing about 200 000 annually and
leaving millions of others debilitated. Current diagnostic tools have extremely low validity and are not readily applicable for
rapid diagnosis in rural and remote areas. In low-grade infections, microscopy, the most commonly used method, may have
low sensitivity. For example, in suspected cases, up to five real sample specimens are recommended for increased sensitivity.
The rise of nanotechnology has created the potential to significantly improve the current diagnostic approaches. Conjugating
antibodies with nanoparticles pools the distinctive properties of the nanoparticles with the specificity and selectivity of the anti-
bodies in the recognition of the antigen. This in return leads to a very versatile and specific mixed product with improved analyti-
cal signal which is important for fast, sensitive and real-time point-of-care diagnosis. In this work, we report the use of
nanotechnology to develop a simple and sensitive nano-biosensor which consisted of a nano-strip with immobilized gold
nanoparticles conjugated with bilharzia antibody, and demonstrated its potential for diagnosis of bilharzia antigen. A detection
range of 1.13 × 101 ng mL–1 to 2.3 × 103 ng mL–1 of bilharzia antigen in stool samples and with a limit of detection of 8.3887 ×
10–2 ng mL–1 was attained, indicating the potential of the nano-biosensor to be used to detect bilharzia antigen in stool samples.
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1. Introduction
Bilharzia, also known as schistosomiasis, is one of the most
neglected tropical diseases (NTDs), yet it is still affecting more
than 250 million people, killing about 200 000 annually and
leaving millions others debilitated, especially in the remote rural
populations.1 Bilharzia has a negative direct impact on health. In
addition, it also fuels the vicious circle of poverty and stigma that
leaves people unable to work, go to school, or participate in
family and community life.1 It is caused by the schistosome para-
site2 and in human, it is caused by S. haematobium, S. mansoni,
S. japonicum and less frequently by S. mekongi and S. intercalatum.3
The infection with cercariae arises when the skin gets into con-
tact with infested water.3b–d
Diagnosis is a key step in the treatment and control of this
parasitic disease, since case detection, morbidity assessment and
the evaluation of control strategies all build from the diagnostic
results. The current diagnostic methods for bilharzia include the
microscopic determination of parasite eggs either in urine or
stool or by antibody-antigen detection methods.4 In addition,
the sensitivity of the diagnosis also depends on the severity of
the infection. For example, in low-grade infections, the sensitiv-
ity of one microscopic examination may be very low and when
bilharzia is suspected up to five urine or stool specimens are
recommended for microscopic analysis to improve the sensitiv-
ity of the examinations.5 Moreover, based on the method and
the time used in the post-infected host, the current antibody
assays report a sensitivity in the range of between 65 and 86 %.5
Some commonly used methods such as the ones based on the
detection of antibodies against the soluble egg antigen (SEA)
may lead to the retention of the eggs and constant secretion
of the SEA by the deposited egg, hence the antibodies may
be elicited for an indefinite period of time after the primary
infection, irrespective of successful treatment. These methods
thus suffer from low sensitivity6 and in addition, they often give
unreliable results especially in areas of prevalence.7
Nanotechnology, which has the potential to offer not only
improvement to current approaches, but also unexpectedly
delivers many new tools and capabilities,8 can be used to
improve the sensitivity of these methods. The application of
metal nanoparticles in immune-sensing has shown great poten-
tial in developing versatile point-of-care diagnostic devices
which are highly sensitive.9 This is due the small size of the
metal nanoparticles (NPs) which makes their physical and
chemical properties exceptional as compared to their corre-
sponding bulk materials. Gold nanoparticles (AuNPs) for
instance, have drawn widespread application in biomedical
diagnostic assays and for imaging10 due to their biocompatibility,
high stability and ease of characterization. For example, AuNP–
antibody conjugates have been used in immunohistochemistry,
biosensors and immunoassays as either optical or electrochemi-
cal biomarkers.11 AuNPs have also been attached to protein
molecules for drug delivery targeting cancer cells,12 attached to
glucose oxidase for glucose biosensing13 and to antibodies for
spectro-recognition.14
Conjugating antibodies with nanoparticles pools the distinc-
tive properties of the nanoparticles with the specificity and
selectivity of the antibodies in the recognition of the antigen.15
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This results in a highly versatile and specific hybrid product with
improved analytical signal important for rapid, sensitive and
real-time point-of-care diagnosis. The need to perform rapid
‘in situ’ analyses has seen the use of disposable screen-printed
electrodes (SPEs) replace the conventional electrodes.16 Due to
the heterogenic nature of the screen-printing technology
together with the properties of solid electrodes, SPEs have
numerous benefits as compared to others for industrial sensor
production.17 For example, gold SPEs may be coated with
additional layers by again screen-printing, adsorption, electro-
polymerization, etc.,17–18 which can allow for automated, rapid
and point-of-care application.
In this work, we have used nanotechnology to develop a
simple and sensitive nano-biosensor for detection of bilharzia
antigen (SEA) using gold screen-printed electrodes and demon-
strated their potential for diagnosis of bilharzia antigen. The
objective of this study therefore was to develop a versatile device
for the diagnosis of SEA with a low detection limit. Kenya
depends on agricultural farming where bilharzia is prevalent
in rice-growing areas such as Mwea, Coast and Nyanza. This
eventually affects the economy since many people are unable to
go to work and even school-going children may not be able to
attend school. This nano-biosensor can be fabricated to nano-
kits using the screen-printed electrodes as strips which can be
distributed to bilharzia endemic areas in Kenya like Nyanza and
Mwea regions to facilitate early diagnosis and treatment of
bilharzia.
2. Materials and Methods
2.1. Reagents
Dimethylaminopropyl-N’Ethylcarbodiimide N-3 hydrochlo-
ride (EDC/EDC-HCl) and N-Hydroxy succinimide (NHS) were
purchased from Fluka. Sodium phosphate monohydrate,
Sodium phosphate dihydrate, sodium chloride and sodium
hydrogen carbonate of analytical grade, monodispersed 10 nm
Au nanoparticles, stabilized in 0.1 mM PBS and reactant-
free were obtained from Sigma Aldrich (St. Louis, MO, USA).
bovine serum albumin (BSA) was purchased from Thermo
Fischer Scientific (Pittsburgh, PA). Rabbit anti-schistosome and
mouse schistosome-SEA were prepared at the Kenya Medical
Research Institute (KEMRI), Nairobi, Kenya. Infected human
faecal samples were obtained from Kandongu Health Dispen-
saries in Mwea Rice Irrigation scheme, Kirinyaga County,
Kenya.
2.2. Preparation of SEA and Anti-schistosoma Antibody (IgG)
This procedure was done at the Centre for Biotechnology
Research and Development (CBRD) at KEMRI, Kenya, and is
reported in the literature.19 Briefly, Schistosoma mansoni parasite
eggs were perfused from the liver and gut of infected mice,
crushed and ground in pre-cooled mortars. The supernatant
obtained after centrifuging was collected and concentrated to
obtain SEA. Adult rabbits were injected with SEA and the serum
extracted 6 weeks post-injection to obtain the antibody. The
concentration of the antibody was determined using direct
ELISA.20
2.3. Nano Biosensor Procedures
2.3.1. Instrumentation
The biological interaction of anti-schistosome with the SEA
was investigated using a BASi Epsilon Potentiostat (Electro-
chemical Workstation, Version 2.13.77, USA). The low tempera-
ture gold screen-printed electrodes obtained from Dropsens,
Spain, were connected to the potentiostat via a holder (DS
250BT) or a glass cell (DS 220BT) as shown in Fig. 1a,b. The conju-
gate was immobilized on the working electrode of SPE. The
scans were done in triplicate and the controls involved running
the sensor without the analyte.
2.3.2. Preparation of Gold Nanoparticle Anti-bilharzia Conjugate
(AuNP-IgG) Conjugate
The gold nanoparticle anti-bilharzia conjugate was prepared
as reported in literature.19 Briefly, an aliquot of rabbit anti-
bilharzia IgG (28.9 mg mL–1) stock solution was diluted with
0.01M PBS (pH 7.4) to 10 µl mL–1. A solution containing a mixture
of 1 mL of 0.1 M EDC and 1 mL of 0.4 M NHS was prepared in
5 mL 0.01 M PBS. 50 µl of 10 nm AuNPs stabilized in 0.01 M PBS
was added to the mixture followed by 10 µl of 10 µg mL–1 rabbit
anti-bilharzia. This was gently stirred for half an hour at room
temperature. The suspension was collected via centrifugation
at 3500 rpm for 1 h. The supernatant was discarded and the
suspension washed twice with 0.01 M PBS before re-suspending
it in the buffer solution and kept at 4 °C. This procedure was then
repeated two more times.
2.3.3. Optimization of AuNP-IgG Conjugate
The sensor was optimized for several parameters which
included concentration of reagents used in the preparation of
the conjugate, time of incubation (assay time) and ratio of
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Figure 1 Representative set-up for electrochemical study of the Ab-Ag interaction using low temperature screen-printed electrodes (a) SPE model
DS250BT and (b) SPE model DS220BT.
(a) (b)
EDC:NHS used. The optimization was achieved by carrying out
the experiments with different concentrations of the reagents
and at various assay times. The optimum operating conditions
were determined by comparing the signals obtained for the
analysis and the assay time.
2.3.4. Immobilization of the AuNP-IgG Conjugate on the Sensor
Platform
The sensor set-up involved the immobilization of an opti-
mized gold nanoparticle-anti-bilharzia conjugate (AuNP-IgG)
on the working electrode, a gold-coated screen-printed elec-
trode as shown in Scheme 1. Briefly, 1.0 µg mL–1 conjugate was
prepared and 10 µl immobilized on the working electrode of the
two types of gold ink SPEs (DS 250BT and DS 220BT) for 1 h. This
was followed by washing with phosphate buffer with Tween-20
(PBST) and then deactivated with 1 % BSA for 15 min to block
any free unbound sites of the antibody. The procedure was
done in triplicate. The two models of gold SPEs used in the study
were set as shown in Fig. 1a,b. The SPEs were then characterized
using used cyclic voltammetry (CV) and differential pulse
voltammetry (DPV).
2.3.5. Rabbit Anti-schistosome and Mouse Schistosome SEA
Interaction
Different concentrations of Mouse Schistosome SEA
0.05–50 ng mL–1 were prepared in 0.01M PBS (pH = 7.6) buffer
and used as the analyte for the interaction of the immobilized
rabbit anti-schistosome antibody which was conjugated to
AuNPs. The sensor was incubated in SEA for a fixed period of 1 h.
This procedure was done in triplicate. The biological recognition
that arises from the Ab-Ag interaction brought about changes in
the electrochemical activity of the nanoparticles on the surface of
the electrode. These changes were then characterized using CV
and DPV. The CV scans were done at a scan rate of 50 mV s–1
between 0 and 1.5 V whereas DPV was ran between –0.1 V and
–0.5 V, pulse amplitude 50 mV and pulse width 50 ms.
2.4. Preparation of Faecal Samples for Analysis and
Determination of SEA in the Real Samples
100 mg of the sample was diluted with 400 µl of 0.01 M PBS. The
mixture was vortexed for 5 min to loosen the S. mansoni eggs and
release the miracidia. The mixture was then decanted to separate
the insoluble material and large debris. Clearer liquid part of the
sample was obtained by centrifugation at 3000 rpm for 1 h. 100 µl
of the supernatant was carefully drawn, labelled and stored for
analysis at 4 °C. The pellet was discarded. To investigate the
workability of the sensor, the supernatant obtained from the
infected human faecal material was diluted to a factor 4 using
0.01 M PBS buffer. This was then analyzed using the same proce-
dure used for the standards of SEA above. The real concentration
of the analyte in the sample was then obtained from the calibra-
tion curve for the SEA standards.
3. Results and Discussion
3.1. Preparation and Characterization of the Nanoparticle-
anti-bilharzia Conjugate
The characterization of the nanoparticle-anti-bilharzia conju-
gate was done using UV/Vis and CV. The UV/Vis results as
shown in Fig. 2a indicate a reduction in the peak absorbance of
AuNPs in the conjugate as compared to the bare nanoparticles.19
This was as a result of the steric hindrance brought about by the
antibodies that are covalently bonded on the surface of the
nanoparticle during the formation of the conjugate. This
hindrance reduces the exposure of AuNPs to the incident light,
thus reduced oscillation of electrons in the conduction band.22
Furthermore, the peak is observed to appear at the same wave-
length (640 nm), an indication of the stability of the conjugate so
formed.23 The zero valent cross-linker EDC-HCl is known to
react with carboxylated AuNPs in the presence of NHS to
form amine-reactive NHS esters. Subsequent addition of anti-
bilharzia antibodies results in coupling between the AuNPs and
primary amines on the antibody via stable amide bonding.19
The electrochemical characterization of the nanoparticle-anti-
bilharzia conjugate was done using cyclic voltammetry (CV).
One of the major features in CV is its ability to provide informa-
tion about the chemistry of redox couples. Electroactive com-
pounds give peaks at the oxidation and reduction potentials
which are characteristic of the cation undergoing the redox
process. As shown in Fig. 2b, CV results19 indicated a decrease in
the peaks for the nanoparticle-anti-bilharzia conjugate as com-
pared with the peaks for the AuNPs alone. This indicated an
insulation of the active part of the electrode by the conjugate
since it is not electroactive. No peak was observed with the anti-
body alone implying that the protein molecule is not electro-
active and therefore the reduction of the anodic currents proves
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Scheme 1
The immunosensor protocol for analyte determination based on direct determination of the electrochemical signal obtained after Ab-Ag
interaction. The peak currents are found to be proportional to the concentration of SEA.21
that a new compound consisting of the nanoparticle and the
antibody has been formed.
3.2. Study of the Nanoparticle-anti-bilharzia Conjugate and
the Soluble Egg Antigen (SEA) Interaction
The nano-biosensor was characterized by studying the inter-
action of the nanoparticle-anti-bilharzia conjugate with the SEA
and this was done using cyclic voltammetry and differential
pulse voltammetry.
3.2.1. Cyclic Voltammetry (CV)
CV was used to characterize the electrode surface where the
nanoparticle-antibody conjugate was immobilized. Oxidizing
the gold nanoparticles (AuNPs) in the presence of the rabbit
anti-bilharzia antibody formed reactive gold oxides accompa-
nied by electrons which produced redox signal. For screen-
printed gold electrodes (Model DS 250BT), the scan indicated
anodic and cathodic peaks 920 mV and 325 mV, respectively, for
gold electrodes.24 The peak currents of the anodic and cathodic
peaks indicated insignificant changes after several cycles and
this indicated the stability as well as the reproducibility of the
AuNPs-rabbit anti-bilharzia conjugate. After the incubation of
the conjugate modified electrode with different concentrations
of standards of SEA prepared in PBS buffer (pH 7.4), the results
indicated a biospecific molecular recognition, forming an anti-
body-antigen complex evidenced by the change in the redox
current25 as shown in Fig. 3a. The complex formation on the
surface of the electrode led to an insulation of the surface toward
the redox couple. This insulation mirrored the differences in the
effective diffusion of ions to the electrode surface due to the
Ab-Ag interaction. A calibration curve for the change in the
anodic peak current versus the SEA concentration as shown in
Fig. 3b indicated a limit of detection of 8.387 × 10–2 mL calculated
as three times the standard deviation of the blank. To establish
that the peak current reduction was due to the antibody-antigen
interaction, a control was performed. The control was just a
buffer solution without incubation of the SEA. The peak current
showed insignificant change and this indicated that the
recorded current decrease was due to the SEA and its antibody
interaction.
For screen-printed gold electrodes (Model DS 220BT) the scans
revealed an anodic and a cathodic peak at 950 mV and 325 mV,
respectively, which was similar to the observation made for
Model DS 250BT. As expected, the peak currents recorded
indicated no significant changes, indicating the stability and
reproducibility of the conjugate. Varying standards of SEA were
then incubated with the conjugate and CV scans conducted
(Fig. 4a). A calibration curve for the anodic peak current versus
the SEA concentration as shown in Fig. 4b revealed a limit of
detection of 5.45 × 10–2 ng mL–1 calculated as three times the
standard deviation of the blank.
3.2.2. Differential Pulse Voltammetry
Differential pulse voltammetry (DPV) was used to estimate the
linear range, limit of detection and individual quantification of
SEA in various real samples since it has a much higher current
sensitivity and selectivity than CV.26 It was noted that the peak
current (Ip) at –0.11 V was decreasing with the increase in the
concentration of SEA. This was because the complex formed at
the surface of the electrode led to an insulation of the electrode
surface towards the redox couple reflecting the differences in
the effective diffusion of ions to the electrode surface due to the
Ab-Ag complex interaction. The extent of insulation was found
to be dependent on the concentration of SEA used and it
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Figure 2 (a) UV spectrum of 10 µl AuNPs and AuNP-IgG conjugate in 0.01 M PBS,19 n = 3. (b) Cyclic voltammograms of AuNPs and AuNP-IgG conju-
gate immobilized on GCE electrodes for 1 h19, n = 3.
(a)
(b)
reduced in the intensity of the peak currents as the concentra-
tion was increased (Fig. 5a). The peak currents were noted to
decrease with the increase in concentration of SEA incubated
with the conjugate modified SPE. For SPE (Model DS 220BT), the
peak current appeared at –0.274V (Fig. 5a). A plot of concentra-
tion of SEA against the change in peak currents gave detection
limits of 3.64 × 10–5 ng mL–1 calculated as three times the stan-
dard deviation of the blank (Fig. 5b).
3.3. Determination of Schistosomiasis mansoni SEA in Human
Faecal Material
The performance of the biosensor was validated using human
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Figure 3 (a) Representative cyclic voltammograms obtained after incubating the AuNPs-rabbit anti-bilharzia antibody modified screen-printed gold
electrodes (Model DS 250BT) in varying concentrations of SEA, n = 3. (b) SPE (Model DS 250BT) nano-biosensor CV calibration curve for the change
in anodic peak currents versus log of concentration of SEA, n = 3.
Figure 4 (a) Representative cyclic voltammograms obtained after incubating the AuNPs-rabbit anti-bilharzia antibody modified screen-printed gold




faecal samples suspected to be infected with a species of
Schistosoma. The samples were diluted with 0.01 M PBS (pH =
7.4) buffer. 10 ml of the mixture was vortexed for 5 min to break
the eggs and release miracidia. This was then centrifuged for 1 h
at 3000 rpm to separate the debris. 20 µl of the supernatant was
diluted to a factor 4 and analyzed using both CV and DPV with
the nano-biosensor. The actual concentration of the sample was
determined from the equation of the regression line obtained
after running a series of standards of SEA.
3.4. Reproducibility and Selectivity Tests
The reproducibility of the nano-biosensor based on the Ab-Ag
interaction in the presence of SEA was investigated and only
a small difference in both CV and DPV peak current was
observed. The relative standard deviation was less than 10 %
when five repeats with different SPE electrodes and different
times were measured, indicating that the reproducibility of the
nano-biosensor is acceptable in these experiments. 20 µl of a
sample whose concentration is known was spiked with different
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Figure 4 (Continued) (b) SPE (Model DS 220BT) nano-biosensor CV calibration curve for the change in anodic peak currents verseslog of concentra-
tion of SEA, n = 3.
Figure 5 (a) Representative differential pulse voltammograms obtained after incubating the AuNPs-rabbit anti-schistosome antibody modified
screen-printed gold electrodes (Model DS 220BT) in varying concentrations of SEA, n = 3. (b) SPE (Model DS 220BT) nano-biosensor DPV calibration




concentrations of standards of SEA and then analyzed with the
nano-biosensor using the two techniques. The concentrations
of SEA standards spiked in the sample were 0.5, 5.0 and
50.0 ng mL–1 after constructing calibration curves for SEA stan-
dard solutions between 5.0 × 10–2 ng mL–1 and 5.0 × 102 ng mL–1.
The response from the nano-biosensor of each of spiked sample
was then compared to the response of the standard of SEA
concentration and the values used to calculate the recovery. This
showed an increase in the response as a result of increase in
concentration. After subtracting the blank, the recoveries were
then calculated using the following equation:
% Recovery =
Response signal of spiked sample
Response signal of standard
×100
The percentage recoveries were found to be between 75 and
92 % for CV with an average of 80.34 % and between 71 and 96 %
with an average of 85.2 % for DPV. These averages indicate a
good recovery and may imply that there were less or no sources
of interference in the stool samples. Therefore this nano-bio-
sensor can be used to detect SEA in faecal material of patients
with Schistosoma mansoni.
4. Conclusion
We have developed and validated the chemistry of a nano-
biosensor for the detection of bilharzia in real samples using
screen-printed electrodes. The nanobiosensor was tested and
validated using real stool samples. A detection range of 1.13 ×
101 ng mL–1 to 2.3 × 103 ng mL–1 of bilharzia antigen in stool
samples and with a limit of detection of 8.3887 × 10–2 ng mL–1 was
obtained indicating the potential of the strips to be used for
point-of-care devices to detect bilharzia antigen in real samples.
A reproducibility of 1.5 % was also obtained. This nano-bio-
sensor can be fabricated to nano-kits which can be distributed
to bilharzia-endemic areas in Kenya like Nyanza and Mwea
regions to facilitate early diagnosis and treatment of bilharzia.
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